Grace Therapeutics (GRCE) Non-Current Assets (2017 - 2026)
Grace Therapeutics (GRCE) recorded Non-Current Assets of $35.74 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 27.5% from $49.28 million a year earlier and down 27.5% from the prior quarter.
Grace Therapeutics (GRCE) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Non-Current Assets of $49.27 million, unchanged from FY2025.
- Annual Non-Current Assets has a five-year compound annual growth rate of 256.1% (FY2021 to FY2026).
- Across earlier fiscal years, Non-Current Assets came in at $49.28 million in FY2025 (unchanged), $49.29 million in FY2024 (-1.1%), $49.83 million in FY2023 (-40.2%) and $83.34 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Non-Current Assets since fiscal Q1 2022.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 27.8% in fiscal Q2 2023, against a decline of 40.9% in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $49.27 million (Q4 2026), $49.28 million (Q3 2026) and $49.28 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 35.74 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.74 Mn |
| Mar 31, 2026 | 49.27 Mn |
| Dec 31, 2025 | 49.28 Mn |
| Sep 30, 2025 | 49.28 Mn |
| Jun 30, 2025 | 49.28 Mn |
| Mar 31, 2025 | 49.28 Mn |
| Dec 31, 2024 | 49.29 Mn |
| Sep 30, 2024 | 49.29 Mn |
| Jun 30, 2024 | 49.29 Mn |
| Mar 31, 2024 | 49.29 Mn |
| Dec 31, 2023 | 49.30 Mn |
| Sep 30, 2023 | 49.32 Mn |
| Jun 30, 2023 | 49.42 Mn |
| Mar 31, 2023 | 49.83 Mn |
| Dec 31, 2022 | 83.37 Mn |
| Sep 30, 2022 | 83.41 Mn |
| Jun 30, 2022 | 83.68 Mn |
| Mar 31, 2022 | 83.34 Mn |
| Dec 31, 2021 | 65.23 Mn |
| Sep 30, 2021 | 65.25 Mn |
Grace Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();